Oxford Pharmascience Group (OXP)

 

Latest News

Oxford Pharmascience narrows FY pretax loss

Oxford Pharmascience has roughly halved its FY pretax loss to 1.9m, from a loss of 3.9m a year earlier. Revenues totalled 7...

Final Results

RNS Number: 0823Z Oxford Pharmascience Group PLC 10 March 2017 10 March 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Final Results for the year ended 31 December 2016 Oxford Pharmascience Group plc (AIM: OXP), the speciality pharmaceutical company that redevelops medicines to make them better, safer and easie...

Notice of Results

RNS Number: 6745Y Oxford Pharmascience Group PLC 07 March 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") Notice of Results Oxford Pharmascience, the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, expects to announce its annual audited results for the year en...

Company Update

RNS Number: 6402X Oxford Pharmascience Group PLC 23 February 2017 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") OXPzero TM Ibuprofen - Positive Exploratory PK Study Data Oxford Pharmascience (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, p...

All News

DateHeadlineSource
10-03-17Oxford Pharmascience narrows FY pretax lossStockMarketWire
10-03-17Final ResultsRNS
07-03-17Notice of ResultsRNS
23-02-17Company UpdateRNS
25-01-17Oxford Pharmascience - Company updateBRR Media
17-01-17Oxford Pharmascience issues company updateStockMarketWire
17-01-17Company UpdateRNS
09-11-16R&D UpdateRNS
19-10-16Here's what Neil Woodford is buying and sellingInteractive Investor
13-09-16Oxford Pharmascience - Interim results 2016BRR Media
07-09-16Interim results for the 6 months to 30 June 2016RNS
21-07-16Oxford Pharmascience downgraded by BeaufortStockMarketWire
21-07-16Broker Forecast - Beaufort Securities issues a broker note on Oxford Pharmascience Group PLCStockMarketWire
20-07-16FTSE rises on pharmas, financials as miners ebbStockMarketWire
20-07-16Commercial Update & Directorate ChangeRNS
22-06-16Result of AGMRNS
20-05-16Shares Magazine Investor Evening PresentationRNS
22-04-16OXP to exhibit at the Master Investor Show 2016RNS
22-04-16Oxford Pharmascience Group plc - Company updateBRR Media
19-04-16Positive Regulatory Advice from MHRARNS
11-03-16Grant of Share OptionsRNS
04-03-16Oxford Pharmascience widens FY pretax lossStockMarketWire
04-03-16Final ResultsRNS
01-03-16Oxford Pharmascience schedules FY results StockMarketWire
01-03-16Notice of ResultsRNS
25-02-16Appointment of DirectorRNS
29-01-16Change of Registered OfficeRNS
25-01-16OXP primed for partnering talks on OXPzero NSAIDSStockMarketWire
25-01-16Entering Partnering DiscussionsRNS
04-12-15Oxford Pharmascience CFO granted share optionsStockMarketWire
04-12-15Grant of Share OptionsRNS
01-12-15Holding(s) in CompanyRNS
05-11-15OXP updates on OXPzero Ibuprofen StockMarketWire
05-11-15Successful Completion of PoC for OXPzero IbuprofenRNS
05-11-15Oxford Pharmascience - Successful completion of PoC for OXPzero Ibuprofen BRR Media
22-09-15Interim results for the 6 months to 30 June 2015RNS
16-09-15Notice of Interim ResultsRNS
12-08-15Preliminary PK Data & Initiation of Further StudyRNS
12-08-15Preliminary PK Data & Initiation of Further StudyBRR Media
31-07-15Results from Pilot Clinical Study of OXP500RNS

RSS feeds

  • Editorial news feed for LSE:OXP Editorial
  • Regulatory news feed for LSE:OXP Regulatory